Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bites and Stings × abiraterone × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Prostatic Neoplasms, Castration-Resistant 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Bites and Stings 1

Interventions

enzalutamide 1 durvalumab 1 blinatumomab 1 atezolizumab 1 abiraterone 1 Hydroxyurea 1 Etoposide 1 Carboplatin 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04221542 2026-03-06

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Amgen

Phase 1 Recruiting

Bites and Stings, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡